Cequa 0.09% ophthalmic solution Images
Generic Name: cyclosporine
This medication has been identified as Cequa 0.09% ophthalmic solution. It is supplied by Sun Pharmaceutical Industries Inc.
Cequa is used in the treatment of Dry Eye Disease and belongs to the drug class miscellaneous ophthalmic agents. Risk cannot be ruled out during pregnancy. Cequa 0.09% ophthalmic solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Cequa
- Generic Name
- cyclosporine
- Strength
- 0.09% ophthalmic solution
- Availability
- Prescription only
- Drug Class
- Miscellaneous ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 47335-0506
See also:
Restasis
Restasis is used to treat chronic dry eye that may be caused by inflammation. Learn about side ...
Chantix
Chantix is a smoking cessation medicine used with behavior modification and counseling to help you ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Xiidra
Xiidra (lifitegrast 5%) is an eye drop solution that is used twice daily in each eye to treat the ...
Miebo
Miebo (perfluorohexyloctane) is used to treat the signs and symptoms of dry eye disease. Includes ...
Lotemax
Lotemax and Lotemax SM (loteprednol etabonate) are corticosteroid medications used to help treat ...
Vevye
Vevye is a solution of cyclosporine 0.1% that may be used in the eyes to treat the signs and ...
More about Cequa (cyclosporine ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (41)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous ophthalmic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.